Evidence map›Paper›PMID 30375177›Full record

ArticleTransboundary and emerging diseases2019

GFP tagging of Brucella melitensis Rev1 allows the identification of vaccinated sheep.

Ana Zabalza-Baranguá, Beatriz San-Román, Carlos Chacón-Díaz, María-Jesús de Miguel, Pilar-María Muñoz, Maite Iriarte, José-María Blasco, María-Jesús Grilló

Open access · hybridAbstract read
In one paragraph

Article in Transboundary and emerging diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Immune Response to MucosalFrontiers in immunology · 2019
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Ana Zabalza-BaranguáInstituto de Agrobiotecnología (IdAB, CSIC-Gobierno de Navarra), Mutilva, Navarra, Spain.
Beatriz San-RománInstituto de Agrobiotecnología (IdAB, CSIC-Gobierno de Navarra), Mutilva, Navarra, Spain.
Carlos Chacón-DíazCentro de Investigación en Enfermedades Tropicales, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica.
María-Jesús de MiguelCentro de Investigación y Tecnología Agroalimentaria (CITA), Instituto Agroalimentario de Aragón (IA2), Gobierno de Aragón, Zaragoza, Spain.
Pilar-María MuñozCentro de Investigación y Tecnología Agroalimentaria (CITA), Instituto Agroalimentario de Aragón (IA2), Gobierno de Aragón, Zaragoza, Spain.
Maite IriarteInstituto de Salud Tropical - Dpto. de Microbiología y Parasitología, Universidad de Navarra, Pamplona, Spain.
José-María BlascoCentro de Investigación y Tecnología Agroalimentaria (CITA), Instituto Agroalimentario de Aragón (IA2), Gobierno de Aragón, Zaragoza, Spain.
María-Jesús GrillóInstituto de Agrobiotecnología (IdAB, CSIC-Gobierno de Navarra), Mutilva, Navarra, Spain.ORCID http://orcid.org/0000-0002-1819-0186
Centro de Investigación y Tecnología Agroalimentaria de Aragón · ESGobierno de Navarra · ESInstituto de Salud Pública de Navarra · ESUniversidad de Costa Rica · CR

Funding

CSIC-CRUSA Foundation bilateral project 2010CR0005Secretaría de Estado de Investigación, Desarrollo e Innovación AGL2011-30453-C04-01Secretaría de Estado de Investigación, Desarrollo e Innovación AGL2014-58795-C04Secretaría de Estado de Investigación, Desarrollo e Innovación RTC-2015-3618-1
6 · The paper itself

Abstract

Brucellosis is a worldwide zoonosis causing important economic loss and a public health problem. Small ruminants are the preferred hosts of Brucella melitensis and thus the main source of human infections. Effective control of sheep and goat brucellosis has been achieved in several countries through vaccination with the live-attenuated B. melitensis Rev1 vaccine. However, Rev1 induces a long-lasting serological response that hinders the differentiation between infected and vaccinated animals. A Rev1::gfp strain expressing constitutively the Green Fluorescent Protein (GFP) was built by stable insertion of a mini-Tn7-gfp in the glmS-recG non-codifying chromosomal region. An associated indirect ELISA-GFP was developed to identify anti-GFP antibodies in vaccinated animals. The resulting Rev1::gfp kept the biological properties of the Rev1 reference strain, including residual virulence and efficacy in mice, and was readily distinguished from Rev1 and other Brucella field strains by direct visualization under ultraviolet illumination, fluorescence microscopy and a multiplex PCR-GFP. The Rev1::gfp strain did not elicit anti-GFP antibodies itself in lambs but when applied in combination with recombinant GFP induced an intense and long-lasting (>9 months) anti-GFP serological response readily detectable by the ELISA-GFP. Overall, our results confirm that Rev1 GFP-tagging can be a suitable alternative for identifying vaccinated sheep in infected contexts.

Indexed as

AnimalsBrucella melitensisBrucella VaccineBrucellosisEnzyme-Linked Immunosorbent AssayFemaleGreen Fluorescent ProteinsImmunoglobulin GLuminescent AgentsMaleMiceMice, Inbred BALB CMicroscopy, FluorescenceSheepSheep DiseasesVaccinationBrucella VaccineGreen Fluorescent ProteinsImmunoglobulin GLuminescent AgentsVaccines, AttenuatedBrucella melitensisELISA-GFPmini-Tn7-gfpsheepvaccines

Identifiers

PMID30375177
PMCPMC7379934
OpenAlexW2899168269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.